Aston Martin predicts U.S. tariffs impact, plans to raise $161.8M from investments

Investing.com -- Aston Martin (LON:AML), the British luxury sports-car manufacturer, anticipates that U.S. tariffs will hamper its sales volumes this year.

The company is now forecasting a modest growth compared to last year, a downgrade from its prior projection of mid-single-percentage digit growth.

In a bid to bolster its finances, the company plans to raise £125 million ($161.8 million) through an investment by the Yew Tree Consortium, led by Executive Chair Lawrence Stroll, and a sale of shares in its Formula One team.

Yew Tree has proposed increasing its stake in Aston Martin to approximately 33%, by purchasing about 8% of the company for £52.5 million at a premium.

The shares are proposed to be bought at 70 pence each, a 7.3% premium to the closing price on Friday, the company disclosed.

The investor also indicated an interest in raising its stake to 35% when feasible, according to Aston Martin.

Simultaneously, Aston Martin is planning to sell its minority investment in the Aston Martin Aramco (TADAWUL:2222) Formula One Team. The sale is expected to be at a premium to the current book value of approximately £74 million.

These measures are intended to strengthen Aston Martin’s balance sheet and provide additional leeway for future investments, the company stated.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.Should you invest $2,000 in AML right now?

With AML making headlines, savvy investors are asking: Is it truly valued fairly? In a market full of overpriced darlings, identifying true value can be challenging. InvestingPro's advanced AI algorithms have analyzed AML alongside thousands of other stocks to uncover hidden gems. These undervalued stocks, potentially including AML, could offer substantial returns as the market corrects. In 2024 alone, our AI identified several undervalued stocks that later surged by 30 or more. Is AML poised for similar growth? Don't miss the opportunity to find out.

Reveal Undervalued Stocks Now